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prevention of preterm birth: a case report
Begoña Martinez de TejadaAbstract
Background: Preterm delivery is a major health problem and contributes to more than 50% of all neonatal and
infant deaths. Recently, there has been a renewed interest in the use of cervical pessaries as a safe and effective
intervention with few maternal side-effects for the prevention of preterm birth in both single and twin pregnancies.
Case presentation: A 43-year-old gravida 5, para 1 (previous preterm birth at 24 weeks) patient with an in vitro
fertilization twin pregnancy had an Arabin cervical pessary placed at 19 weeks of pregnancy due to the presence of
cervical funneling identified by ultrasound screening. She developed chorioamnionitis and sepsis and delivered at
21 3/7 weeks after extraction of the pessary.
Conclusion: Severe maternal infection may complicate pessary treatment for the prevention of preterm birth.
Careful follow-up is necessary in women with a cervical pessary during pregnancy, particularly when important
funneling is present.
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Preterm birth (PTB) is defined as delivery before 37
completed weeks of gestation and is a major contributor
to perinatal mortality. Among all causes of perinatal
mortality, 50–70% can be attributed to PTB. Similarly,
PTB is the leading cause of neonatal morbidity, mostly
due to respiratory immaturity, intracranial hemorrhage,
and infections. These conditions can result in long-term
neurodevelopmental sequelae, such as intellectual im-
pairment, cerebral palsy, chronic lung disease, deafness,
and blindness [1, 2]. Thus, prevention of spontaneous
PTB remains one of the biggest challenges in obstetric
care.
Vaginal pessaries have been used for centuries to treat
uterine or vaginal vault prolapse. Their use for the pre-
vention of spontaneous PTB has been mostly quite occa-
sional until the recent publication of a randomized
clinical trial that showed a reduction in the rate of PTB
before 34 weeks in the group of women with a shortCorrespondence: Begona.MartinezDeTejada@hcuge.ch
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non-treated group [3]. Cervical pessary has been shown
also to reduce the rate of poor neonatal outcomes in
women with twin pregnancies and a cervical length of
less than the 25th percentile (38 mm) [4]. Pessaries are
described as safe to be used in pregnancy with a chor-
ioamnionitis rate of around 3%. We present here a case
of severe chorioamnionitis and maternal sepsis compli-
cating cervical pessary treatment for the prevention of
PTB in a patient with a twin pregnancy [3, 4].
Case presentation
A 43-year-old gravida 5, para 1 (previous preterm birth
at 24 weeks) patient with a twin pregnancy from in vitro
fertilization (IVF). Her past medical history was signifi-
cant for three previous first trimester miscarriages (the
latter with a cervical cerclage) and a preterm delivery at
25 weeks’ gestation of a girl of 1000 g who died at 1
month of life in Madagascar. Due to an infertility prob-
lem for the past 3 years, the patient had undergone IVF
in Spain to get pregnant. An ultrasound performed at
7 weeks confirmed a dichorial-diamniotic twin preg-
nancy with a long cervical length (>40 mm). She hadle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Fig. 2 Cervical ultrasound at 21 3/7 weeks showing a long cervix
with bulging membranes through the pessary
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gesterone) during the first 14 weeks of pregnancy. The
cervix had been checked again at 9, 12, and 16 weeks
both clinically (long, posterior, and closed) and sonogra-
phically (>40 mm and without funneling). However, dur-
ing a regular pregnancy visit at 19 3/7 weeks, the
ultrasound examination showed a long cervix (48 mm),
but open at about 18 mm along all of its length (Fig. 1).
Clinically, the patient was asymptomatic (no uterine
contractions, no signs/symptoms of infection) and her
uterine cervix was long and almost closed (the mem-
branes were not visualized through the external cervical
os [ECO]). We decided to place an Arabin pessary after
performing wet mount and vaginal and cervical cultures
(all examinations were negative). One week later (20
3/7 weeks), she came back for a check-up. The pessary
was well tolerated and well positioned at speculum exam-
ination; the ECO was 1 cm open and the fetal membranes
were visualized through it, but not bulking.
At 21 2/7 weeks, the patient consulted the emergency
unit for suspicion of rupture of the membranes. At clin-
ical examination, rupture of the membranes was ex-
cluded. The pessary was well positioned, but the
membranes were bulking through the ECO and around
2 cm in the vagina. The ultrasound showed normal am-
niotic fluid, normal growth of both fetuses, and a long
(58 mm), but open cervix (approximately 4 cm) (Fig. 2).
The patient had no uterine contractions, no fever, vagi-
nal secretions were normal and the blood examinations
showed no leucocytosis (12 G/l and 6.7 G/L 6 h later),
but high C-reactive protein (CRP) levels (142 mg/l and
114 mg/l 6 h later). The patient was hospitalized for a
threatened second trimester miscarriage. Several hours
later, the patient started to shiver and developed a high
temperature (39.5 °C). She complained about slight ab-
dominal pain and rupture of the membranes occurred.
A blood test showed high leucocytes (18.5 G/l, 9.5%
non-segmented) and a high CRP (242 mg/l). The patientFig. 1 Cervical ultrasound at 19 3/7 weeks showing a long and
open cervixwas transferred to the labour suite, put on intravenous
antibiotics (amoxicillin and gentamicin) and the pessary
was removed. The cervix was 1 cm long and 1 cm di-
lated. Two hours later, the cervix was dilated at about
4–5 cm.
The patient delivered the first baby, a stillborn girl
(395 g) in breech presentation, followed by delivery of
the second twin, a live boy of 480 g, after artificial rup-
ture of the membranes. The baby died afterwards. The
patient developed septic shock, with hypotension and
bradycardia. She was transferred to the operating theatre
to remove the placentas after intubation and then to the
intensive care unit where she continued the antibiotic
treatment (clindamycin had been added before placental
removal). She was transfused and extubated 18 h later.
She was put on continuous positive airway pressure and
respiratory physiotherapy due to lung oedema. Blood
cultures became negative and placenta culture became
positive for vaginal flora. She was transferred to the ma-
ternity unit 24 h later where she continued the respira-
tory physiotherapy and the antibiotic treatment was
switched to amoxicillin/clavulanic acid orally after 48 h
without fever. The histological examination of the pla-
centa showed acute and diffuse choriomnionitis and
vasculitis.
Discussion
PTB occurs in approximately 7–8% of all live births in
Switzerland [5]. This rate is much higher in some devel-
oped (12% in the USA) and developing countries (18%).
PTB is the major determinant of adverse neonatal out-
come and infant mortality rates range from 400 per
1000 live births at 24 weeks’ gestation to 1.4 at term [2].
Long-term sequelae in PTB survivors include motor,
visual, auditory and cognitive impairment, epilepsy,
behavioural problems, and increased risk of hospital
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a negative emotional and psychosocial impact on parents
and families, which can last well beyond the initial
period of hospitalisation of the preterm baby [1]. The
financial consequences for the public sector of caring for
children born preterm are also a significant burden. [8].
Twins, with a prevalence of 1.5% of pregnancies, account
for approximately 25% of all PTBs.
Recently, the application of a cervical pessary for the
prevention of PTB has generated renewed interest. The
Arabin pessary is the most frequently used for this indi-
cation. The pessary is supposed to function not only by
preventing further opening of the internal os, but also
by changing the inclination of the cervical canal relative
to the uterus. In turn, this may prevent direct pressure
on the membranes as the weight of the uterus is directed
more towards the lower anterior uterine segment. It has
been shown that pessary placement increased cervical
oedema, which could prevent cervical effacement [9]. Of
note, it is recommended not to remove the pessary after
premature rupture of the membranes, which is known
to be a risk factor for chorioamnionitis.
A randomised controlled trial to investigate whether
cervical pessary use could prevent PTB was published in
the Lancet in 2012 [3]. The study included 385 women
with singleton pregnancies and a cervical length less
than 25 mm and showed a significant reduction in the
rate of PTB at less than 34 weeks (6 vs 27%; odds ratio,
0.18 [95% CI 08–0.37]; p <0.001) in the pessary group.
The authors showed also a significant reduction in the
rate of composite neonatal adverse events (3 vs 16%;
odds ratio, 014; [95% CI 0.04–0.39]; p <0001). The rate
of maternal side-effects was similar between the pessary
and the non-pessary groups, except for the rate of vagi-
nal discharge, which was 100% in the pessary group. The
rate of choriomnionitis was 3% in both groups. No ma-
ternal sepsis was reported. In 2013, another randomised
controlled trial was also published on the same topic in
the Lancet, but this time including twin pregnancies [4].
In this study, 813 women were randomised to pessary or
no treatment. There was no difference in the rate of
PTB at less than 37, 32 or 28 weeks or in the rate of ad-
verse neonatal outcomes. In a secondary analysis includ-
ing women with a cervical length less than the 25th
percentile (38 mm), poor perinatal outcome was less fre-
quent in the pessary group (10%) than in the control
group (24%; p = 0.01). Median gestational age at delivery
was also longer in the pessary group than in the control
group (36.4 vs 35 weeks, respectively; p = 0.04). The rate
of chorioamnionitis was 3% in both groups and there
was one case of maternal death in the pessary group (no
reason reported).
We took the decision to insert the pessary in our pa-
tient as the risk for late miscarriage or PTB was highbased on the progressive opening of the cervix. We did
not perform a cerclage as current guidelines do not rec-
ommend cerclage in twin pregnancies as a higher risk of
chorioamnionitis and PTB is reported when the proced-
ure is performed in this setting. When the pessary was
placed, our patient was asymptomatic and the clinical
cervical examination was normal (slight opening of the
ECO); membranes were not bulging. Interestingly, other
authors have reported the beneficial effect of the pessary
even when placed in women with bulging membranes
[9, 10]. PTB is often associated with intrauterine infec-
tion and this risk is higher when decreasing the gesta-
tional age at delivery [11]. It is unknown whether our
patient had intrauterine infection leading to PTB as we
did not perform amniocentesis. We postulate that the
pessary prevented the cervical canal from further efface-
ment and dilatation and thus avoided spontaneous mis-
carriage. As the membranes bulged through the pessary
and were exposed to the vaginal flora, the patient devel-
oped chorioamnionitis and sepsis. If the pessary had not
been placed, our patient would probably have expulsed
the fetus earlier and maternal sepsis could have been
prevented. Once the pessary was removed, cervical dila-
tation and fetal delivery happened very rapidly.
Cervical pessary may be an effective tool for the pre-
vention of PTB as shown in several studies [3, 4, 9, 12].
Nevertheless, uncertainty about its efficacy persists as
other studies have not shown any benefit from the place-
ment of a cervical pessary in singleton or twin pregnan-
cies [13, 14]. We recommend that pregnant women at
high risk for maternal infection, such as those with im-
portant cervical funneling or bulging of the membranes,
should be carefully followed for early diagnosis of infec-
tion and the pessary removed promptly following the ap-
pearance of any sign of infection.
Conclusions
Clinicians should be aware of a possible risk of severe
maternal infectious complications in pregnant women
with placement of a cervical pessary. The pessary should
be removed immediately in the case of a suspicion of in-
fection in order to prevent severe complications.
Abbreviations
CRP: C-reactive protein; ECO: External cervical os; IVF: In vitro fertilisation;
PTB: Preterm birth
Acknowledgements
I thank Rosemary Sudan for her help editing the paper.
Funding
No funding was available.
Availability of data and materials
Not applicable.
Author’s contributions
This paper has been fully written by the only author.
Martinez de Tejada BMC Pregnancy and Childbirth  (2017) 17:34 Page 4 of 4Competing interests
The author declares that she has no competing interests with this work.
Consent for publication
Written informed consent was obtained from the patient for the publication.
Ethics approval and consent to participate
This study received ethical waiver from the local ethical authority.
Received: 23 December 2015 Accepted: 28 December 2016
References
1. Saigal S, Doyle LW. An overview of mortality and sequelae of preterm birth
from infancy to adulthood. Lancet. 2008;371(9608):261–9.
2. Office for National Statistics. Gestation-specific Infant Mortality in England
and Wales, 2012 tables. [http://www.ons.gov.uk/ons/rel/child-health/
gestation-specific-infant-mortality-in-england-and-wales/2012/rft-table-1.xls].
Accessed 21 December 2016.
3. Goya M, Pratcorona L, Merced C, Rodo C, Valle L, Romero A, Juan M,
Rodriguez A, Munoz B, Santacruz B, et al. Cervical pessary in pregnant
women with a short cervix (PECEP): an open-label randomised controlled
trial. Lancet. 2012;379(9828):1800–6.
4. Liem S, Schuit E, Hegeman M, Bais J, de Boer K, Bloemenkamp K, Brons J,
Duvekot H, Bijvank BN, Franssen M, et al. Cervical pessaries for prevention of
preterm birth in women with a multiple pregnancy (ProTWIN): a
multicentre, open-label randomised controlled trial. Lancet. 2013;382(9901):
1341–9.
5. Office Fédéral de la statistique. Procréation, santé des nouveau-nés —
Données, indicateurs Santé des nouveau-nés. [http://www.bfs.admin.ch/bfs/
portal/fr/index/themen/14/02/03/key/04.html]. Accessed 21 December 2016.
6. Doyle LW, Ford G, Davis N. Health and hospitalistions after discharge in
extremely low birth weight infants. Semin Neonatol. 2003;8(2):137–45.
7. Arpino C, Compagnone E, Montanaro ML, Cacciatore D, De Luca A, Cerulli A,
Di Girolamo S, Curatolo P. Preterm birth and neurodevelopmental outcome: a
review. Childs Nerv Syst. 2010;26(9):1139–49.
8. Mangham LJ, Petrou S, Doyle LW, Draper ES, Marlow N. The cost of preterm
birth throughout childhood in England and Wales. Pediatrics. 2009;123(2):
e312–327.
9. Arabin B, Alfirevic Z. Cervical pessaries for prevention of spontaneous
preterm birth: past, present and future. Ultrasound Obstet Gynecol. 2013;
42(4):390–9.
10. Cannie MM, Dobrescu O, Gucciardo L, Strizek B, Ziane S, Sakkas E,
Schoonjans F, Divano L, Jani JC. Arabin cervical pessary in women at high
risk of preterm birth: a magnetic resonance imaging observational follow-
up study. Ultrasound Obstet Gynecol. 2013;42(4):426–33.
11. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of
preterm birth. Lancet. 2008;371(9606):75–84.
12. Liem SM, van Pampus MG, Mol BW, Bekedam DJ. Cervical pessaries for the
prevention of preterm birth: a systematic review. Obstet Gynecol Int. 2013;
2013:576723.
13. Nicolaides KH, Syngelaki A, Poon LC, de Paco MC, Plasencia W, Molina FS,
Picciarelli G, Tul N, Celik E, Lau TK, et al. Cervical pessary placement for
prevention of preterm birth in unselected twin pregnancies: a randomized
controlled trial. Am J Obstet Gynecol. 2016;214(1):3e1–9.
14. Hui SY, Chor CM, Lau TK, Lao TT, Leung TY. Cerclage pessary for preventing
preterm birth in women with a singleton pregnancy and a short cervix at
20 – 24 weeks: a randomized controlled trial. Am J Perinatol. 2013;30(4):
283–8.•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
